<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>ZMUni Compliance Centre</provider_name><provider_url>https://www.zmuni.com/en/</provider_url><author_name>kim</author_name><author_url>https://www.zmuni.com/en/news/author/kim/</author_url><title>China's NCI Approval Updates: Trends in Peptides and HMOs</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="OzkeghZUqp"&gt;&lt;a href="https://www.zmuni.com/en/news/chinasnciapprovalupdatestrendsinpeptidesandhmos/"&gt;China's NCI Approval Updates: Trends in Peptides and HMOs&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.zmuni.com/en/news/chinasnciapprovalupdatestrendsinpeptidesandhmos/embed/#?secret=OzkeghZUqp" width="600" height="338" title="&#x201C;China's NCI Approval Updates: Trends in Peptides and HMOs&#x201D; &#x2014; ZMUni Compliance Centre" data-secret="OzkeghZUqp" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://cdn.zmuni.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://www.zmuni.com/wp-content/uploads/2025/12/1765261102-27.jpg</thumbnail_url><thumbnail_width>2560</thumbnail_width><thumbnail_height>1440</thumbnail_height><description>From December&nbsp;1 to 9, 2025,&nbsp;4 new cosmetic ingredients&nbsp;(NCIs)&nbsp;were notified&nbsp;with the China National Medical Products Administration (NMPA). &nbsp; The technical requirements for the 4&nbsp;new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period. Notably, three out of the four NCIs are peptides. &nbsp; Notification 20250146 - Winkey Technology This ingredient, notified by Winkey Technology, is a type of cyclic hexapeptide. Peptide ingredients among the currently notified NCIs have seen rapid growth over the past two years, but cyclic peptides are still quite limited. Including the NCIs notified this time, there are a</description></oembed>
